Fund Holdings — Iron Triangle Partners LP

Total Portfolio Value:
$631.89M
Total Bought:
$326.08M
Total Sold:
$340.19M
Net Transaction:
-$14.11M
Securities
▲▼
SharesValue
Q1 2025
▲▼
Q2 2025
▲▼
Change
▲▼
Q1 2025
▲▼
Q2 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CVS Health Corporation(CVS)0750,000+750,000$0$51.73M8.19%+$51.73M
Charles River Laboratories International, Inc.(CRL)0320,000+320,000$0$48.55M7.68%+$48.55M
AbbVie Inc.(ABBV)192,819249,997+57,178$40.40M$46.40M7.34%+$6.01M
Merit Medical Systems, Inc.(MMSI)229,738392,783+163,045$24.29M$36.72M5.81%+$12.43M
ICON Public Limited CompanySHS(ICLR)0250,000+250,000$0$36.36M5.75%+$36.36M
Medtronic plcSHS(MDT)0400,000+400,000$0$34.87M5.52%+$34.87M
Tenet Healthcare Corporation(THC)209,454190,000-19,454$28.17M$33.44M5.29%+$5.27M
Intuitive Surgical, Inc.(ISRG)30,00060,000+30,000$14.86M$32.60M5.16%+$17.75M
HCA Healthcare, Inc.(HCA)080,000+80,000$0$30.65M4.85%+$30.65M
Doximity, Inc.CL A(DOCS)360,000471,300+111,300$20.89M$28.91M4.58%+$8.02M
BrightSpring Health Services, Inc.(BTSG)722,3411,200,000+477,659$13.07M$28.31M4.48%+$15.24M
Glaukos Corporation(GKOS)0271,163+271,163$0$28.01M4.43%+$28.01M
Insulet Corporation(PODD)106,02968,041-37,988$27.84M$21.38M3.38%-$6.47M
AdaptHealth Corp.(AHCO)1,614,0451,920,019+305,974$17.50M$18.11M2.87%+$609.5K
Cardinal Health, Inc.(CAH)300,000105,257-194,743$41.33M$17.68M2.80%-$23.65M
Adaptive Biotechnologies Corporation(ADPT)2,134,0611,495,883-638,178$15.86M$17.43M2.76%+$1.57M
Endeavour Silver Corp.(EXK)0300,000+300,000$0$15.94M2.52%+$15.94M
Twist Bioscience Corporation(TWST)423,913424,355+442$16.64M$15.61M2.47%-$1.03M
Guardant Health, Inc.(GH)600,867300,000-300,867$25.60M$15.61M2.47%-$9.98M
BeOne Medicines AGADS(ONC)97,84060,000-37,840$26.63M$14.52M2.30%-$12.10M
Envista Holdings Corporation(NVST)1,232,798620,000-612,798$21.28M$12.11M1.92%-$9.16M
Brookdale Senior Living Inc.(BKD)01,700,000+1,700,000$0$11.83M1.87%+$11.83M
Enhabit Inc
COM
1,140,0001,027,972-112,028$10.02M$9.91M1.57%-$111.0K
Alnylam Pharmaceuticals, Inc.(ALNY)65,40929,339-36,070$17.66M$9.57M1.51%-$8.09M
argenx SEADR(ARGX)27,87415,567-12,307$16.50M$8.58M1.36%-$7.92M
Insmed Incorporated(INSM)070,000+70,000$0$7.04M1.11%+$7.04M
10x Genomics, Inc.CL A(TXG)1,000,0000-1,000,000$8.73M$0—-$8.73M
Agilent Technologies, Inc.(A)208,4380-208,438$24.38M$0—-$24.38M
AstraZeneca PLCADR(AZN)376,3300-376,330$27.66M$0—-$27.66M
Bio-Techne Corporation(TECH)250,0000-250,000$14.66M$0—-$14.66M
Boston Scientific Corporation(BSX)332,1670-332,167$33.51M$0—-$33.51M
DaVita Inc.(DVA)319,5660-319,566$48.88M$0—-$48.88M
Globus Medical, Inc.CL A(GMED)431,2210-431,221$31.57M$0—-$31.57M
Jazz Pharmaceuticals plcSHS USD(JAZZ)130,0000-130,000$16.14M$0—-$16.14M
Neurocrine Biosciences, Inc.(NBIX)146,8360-146,836$16.24M$0—-$16.24M
Teva Pharmaceutical Industries LimitedADS(TEVA)2,217,7300-2,217,730$34.09M$0—-$34.09M
Page 1 of 1
Iron Triangle Partners LP — 13F Holdings — Q2 2025 | TickerTrail